Meeder Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.2K | Sell |
2,957
-6,484
| -69% | -$141K | ﹤0.01% | 342 |
|
|
2025
Q1 | $229K | Sell |
9,441
-2,392
| -20% | -$58K | 0.02% | 236 |
|
|
2024
Q4 | $247K | Buy |
11,833
+7,336
| +163% | +$153K | 0.02% | 205 |
|
|
2024
Q3 | $89.4K | Hold |
4,497
| – | – | 0.01% | 303 |
|
|
2024
Q2 | $69.7K | Buy |
+4,497
| New | +$69.7K | ﹤0.01% | 304 |
|
|
2023
Q1 | – | Sell |
-22
| Closed | -$409 | – | 659 |
|
|
2022
Q4 | $409 | Sell |
22
-75
| -77% | -$1.39K | ﹤0.01% | 755 |
|
|
2022
Q3 | $1K | Buy |
+97
| New | +$1K | ﹤0.01% | 1926 |
|
|
2021
Q4 | – | Sell |
-18,581
| Closed | -$99K | – | 1414 |
|
|
2021
Q3 | $99K | Hold |
18,581
| – | – | 0.01% | 897 |
|
|
2021
Q2 | $107K | Hold |
18,581
| – | – | 0.01% | 889 |
|
|
2021
Q1 | $85K | Buy |
+18,581
| New | +$85K | ﹤0.01% | 955 |
|
|
2020
Q4 | – | Sell |
-18,582
| Closed | -$55K | – | 1945 |
|
|
2020
Q3 | $55K | Hold |
18,582
| – | – | ﹤0.01% | 935 |
|
|
2020
Q2 | $86K | Buy |
18,582
+4,835
| +35% | +$22.4K | 0.01% | 792 |
|
|
2020
Q1 | $52K | Buy |
13,747
+7,255
| +112% | +$27.4K | ﹤0.01% | 891 |
|
|
2019
Q4 | $25K | Buy |
6,492
+3,100
| +91% | +$11.9K | ﹤0.01% | 1278 |
|
|
2019
Q3 | $19K | Sell |
3,392
-9,859
| -74% | -$55.2K | ﹤0.01% | 1329 |
|
|
2019
Q2 | $50K | Buy |
13,251
+11,548
| +678% | +$43.6K | ﹤0.01% | 954 |
|
|
2019
Q1 | $9K | Sell |
1,703
-32,534
| -95% | -$172K | ﹤0.01% | 1264 |
|
|
2018
Q4 | $67K | Buy |
34,237
+22,227
| +185% | +$43.5K | 0.01% | 742 |
|
|
2018
Q3 | $46K | Sell |
12,010
-4,502
| -27% | -$17.2K | ﹤0.01% | 799 |
|
|
2018
Q2 | $51.5K | Buy |
16,512
+14,200
| +614% | +$44.3K | ﹤0.01% | 749 |
|
|
2018
Q1 | $5K | Buy |
2,312
+1,286
| +125% | +$2.78K | ﹤0.01% | 1214 |
|
|
2017
Q4 | $3K | Buy |
+1,026
| New | +$3K | ﹤0.01% | 1420 |
|